Erlotinib in cancer treatment
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/18/suppl_6/vi35/6673291/mdm222.pdf
Reference45 articles.
1. Target-based agent against ErbB receptors and their ligands: a novel approach to cancer treatment;Normanno;Endocr Relat Cancer,2003
2. Blockade of receptors for growth factor: an anticancer therapy;Mendelson;Clin Cancer Res,2000
3. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001
4. Epidermal growth factor-related peptides and their receptors in human malignances;Salomon;Crit Rev Oncol Haematol,1995
5. Targeting HER 1/EGFR: a molecular approach to cancer therapy;Arteaga;Semin Oncol,2003
Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oral in vivo biodistribution of fluorescent labelled nano lipid carrier system of erlotinib using real time optical imaging technique;International Journal of Pharmaceutics;2024-10
2. Microwave‐Assisted Copper‐Catalyzed Synthesis of Triazole‐linked 2‐Amino‐Pyrimidinone based Glycohybrids;ChemistrySelect;2024-08-23
3. Access to 4-((Pyridin-2-yl)amino)quinazolinones via Annulation of 2-Aminobenzonitriles with N′-(Pyridin-2-yl)-N,N-dimethyl Ureas;The Journal of Organic Chemistry;2024-08-21
4. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26
5. A comprehensive overview of the molecular features and therapeutic targets in BRAFV600E‐mutant colorectal cancer;Clinical and Translational Medicine;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3